Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Hematology

The Diagnostic Roadmap: Labs, Biopsies, and Reports

At a Glance

A diagnosis of Hypereosinophilic Syndrome (HES) requires an Absolute Eosinophil Count (AEC) of at least 1,500 cells/µL on two tests a month apart, combined with proof of organ involvement. Doctors use genetic testing and bone marrow biopsies to identify the cause and guide targeted treatments.

Navigating the diagnosis of Hypereosinophilic Syndrome (HES) requires a detective-like approach. Because HES is a diagnosis that relies on both specific blood counts and proof of organ involvement, your medical team will run a battery of tests to rule out common issues and pinpoint the exact nature of your condition [1][2].

Understanding Your Blood Work: The AEC

The most important number on your lab report is the Absolute Eosinophil Count (AEC). You may see “Eosinophils %” on your Complete Blood Count (CBC), but the percentage alone isn’t enough for a diagnosis.

To meet HES criteria, your AEC must be 1,500 cells/µL (often written as ≥1.5×109/L\ge 1.5 \times 10^9/\text{L}) on at least two separate tests, usually taken at least one month apart [3][1].

  • How it’s calculated: Most patient portals display White Blood Cell (WBC) counts in the thousands (e.g., “10.0” means 10,000). To calculate your AEC, multiply your actual WBC number by your Eosinophil percentage (as a decimal). For example:
    10,000×0.20=2,000 cells/µL10,000 \times 0.20 = 2,000 \text{ cells/µL}

Hunting for Genetic Clues

Once high eosinophils are confirmed, doctors must determine why they are high. This involves specialized genetic testing to look for “driver mutations” [4].

  • FISH (Fluorescence In Situ Hybridization): This test uses fluorescent probes to “light up” specific genetic errors, such as the common FIP1L1-PDGFRA fusion [5].
  • NGS (Next-Generation Sequencing): This is a broader search that “spells out” your DNA to find less common mutations in genes like PDGFRB, FGFR1, JAK2, or STAT5b [6][7]. Finding these markers often means your HES will respond to specific targeted therapies [8].

Confirming Organ Damage

HES is not just about the numbers in your blood; it is defined by how those cells affect your body [4]. Doctors use several tools to look for “end-organ damage”:

  • The Heart: An Echocardiogram (TTE) or Cardiac MRI (CMR) is used to look for inflammation or blood clots inside the heart [2][9]. A blood test for Troponin can also detect early, “silent” heart muscle injury [9].
  • The Bone Marrow: A Bone Marrow Biopsy is often necessary to see if the eosinophils are being produced by a cancerous process and to check for increased mast cells or scarring (fibrosis) [10][11].
  • Tissues: If you have a rash or digestive issues, a small biopsy (tissue sample) of the skin or gut may be taken to prove eosinophils are physically invading those areas [12][13].

The ‘Completeness Checklist’ for Your Reports

When you review your records, ensure these key elements are present to confirm a thorough diagnostic workup:

  1. [ ] Two AEC results ≥1,500\ge 1,500 at least one month apart [3].
  2. [ ] FIP1L1-PDGFRA status (tested via FISH or RT-PCR) [5].
  3. [ ] Bone Marrow Analysis (including morphology—what the cells look like under a microscope—and a karyotype—a map of your chromosomes) [10].
  4. [ ] Screening for Secondary Causes (negative tests for parasites, like Strongyloides, and common allergies) [14][15].
  5. [ ] Organ Baseline (an Echocardiogram and a Troponin blood test) [2][9].

Common questions in this guide

How is my Absolute Eosinophil Count (AEC) calculated?
Your AEC is calculated by multiplying your total White Blood Cell (WBC) count by the percentage of eosinophils found in your Complete Blood Count. To meet the criteria for HES, your AEC must be 1,500 cells/µL or higher on at least two separate tests taken a month apart.
Why do I need genetic testing like FISH or NGS for an HES diagnosis?
Genetic testing helps doctors identify specific gene mutations, such as the FIP1L1-PDGFRA fusion, that are causing your body to overproduce eosinophils. Finding these specific genetic markers can determine if your condition will respond to certain targeted therapies.
What role does a bone marrow biopsy play in diagnosing HES?
A bone marrow biopsy helps doctors determine if your high eosinophils are caused by a cancerous process in the blood. It also allows pathologists to check for increased mast cells or scarring in the marrow, which provides crucial information about your specific type of HES.
Why is my doctor checking my heart if I have a blood disorder?
Persistently high levels of eosinophils can cause silent inflammation and damage to organs, particularly the heart. Doctors use echocardiograms and troponin blood tests to monitor for heart muscle injury or blood clots caused by the excess eosinophils.
How long do I need to have high eosinophils to be diagnosed with HES?
A formal HES diagnosis requires your Absolute Eosinophil Count to be persistently elevated at 1,500 cells/µL or higher on at least two tests. These tests are typically taken at least one month apart to confirm the elevation is chronic rather than temporary.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you show me where the AEC is on my CBC report and how it has trended over the last few months?
  2. 2.Which specific gene fusions (like PDGFRA, PDGFRB, or FGFR1) were included in my NGS or FISH panel?
  3. 3.If my bone marrow biopsy showed 'increased mast cells,' what does that mean for my specific HES subtype?
  4. 4.What tests are we using to monitor for 'silent' organ damage, specifically in my heart and lungs?
  5. 5.Should we repeat the AEC test in a month to confirm the diagnosis according to the two-test requirement?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.

    Shomali W, Gotlib J

    American journal of hematology 2024; (99(5)):946-968 doi:10.1002/ajh.27287.

    PMID: 38551368
  2. 2

    Cardiac Abnormalities in Hypereosinophilic Syndromes.

    Hotta VT, Nastari RR, Oishi GDSL, et al.

    Arquivos brasileiros de cardiologia 2024; (121(10)):e20240190 doi:10.36660/abc.20240190.

    PMID: 39607243
  3. 3

    Hypereosinophilic syndrome.

    Noh HR, Magpantay GG

    Allergy and asthma proceedings 2017; (38(1)):78-81 doi:10.2500/aap.2017.38.3995.

    PMID: 28052805
  4. 4

    Clinical Management of Persistent Hypereosinophilia.

    Helbig G, Czachor K

    European journal of haematology 2025; (114(5)):763-774 doi:10.1111/ejh.14396.

    PMID: 39961601
  5. 5

    A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow: A Single Institutional Experience.

    Fang H, Ketterling RP, Hanson CA, et al.

    American journal of clinical pathology 2018; (150(5)):421-431 doi:10.1093/ajcp/aqy064.

    PMID: 30032299
  6. 6

    Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group.

    Shomali W, Colucci P, George TI, et al.

    Leukemia 2023; (37(5)):981-987 doi:10.1038/s41375-023-01859-3.

    PMID: 37076693
  7. 7

    Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.

    Groh M, Fenwarth L, Labro M, et al.

    American journal of hematology 2024; (99(6)):1108-1118 doi:10.1002/ajh.27306.

    PMID: 38563187
  8. 8

    Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome.

    Khoury P, Desmond R, Pabon A, et al.

    Allergy 2016; (71(6)):803-10 doi:10.1111/all.12843.

    PMID: 26797802
  9. 9

    Hypereosinophilic syndrome: considerations for the cardiologist.

    Bondue A, Carpentier C, Roufosse F

    Heart (British Cardiac Society) 2022; (108(3)):164-171 doi:10.1136/heartjnl-2020-317202.

    PMID: 34172539
  10. 10

    Updates on eosinophilic disorders.

    Tzankov A, Reichard KK, Hasserjian RP, et al.

    Virchows Archiv : an international journal of pathology 2023; (482(1)):85-97 doi:10.1007/s00428-022-03402-8.

    PMID: 36068374
  11. 11

    Acute Lymphoblastic Leukemia with Hypereosinophilia in a Child: Case Report and Literature Review.

    Ferruzzi V, Santi E, Gurdo G, et al.

    International journal of environmental research and public health 2018; (15(6)) doi:10.3390/ijerph15061169.

    PMID: 29867057
  12. 12

    Clinical and histopathological features of hypereosinophilic syndrome with cutaneous involvement: The Mayo Clinic Experience.

    Zayas J, Peters MS, Butterfield JH, et al.

    Journal of cutaneous pathology 2023; (50(5)):455-465 doi:10.1111/cup.14410.

    PMID: 36790036
  13. 13

    Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics.

    Kuang FL, Curtin BF, Alao H, et al.

    The journal of allergy and clinical immunology. In practice 2020; (8(8)):2718-2726.e2 doi:10.1016/j.jaip.2020.04.025.

    PMID: 32344186
  14. 14

    Hypereosinophilic syndrome: a rare cause of ST-elevation myocardial infarction and thrombus formation on the aortic valve.

    Jørgensen MD, Schneider IR, Thomsen GN, Dahl JS

    BMJ case reports 2024; (17(4)) doi:10.1136/bcr-2023-259494.

    PMID: 38627047
  15. 15

    [Hypereosinophilic syndrome, case report and diagnostic approach].

    Medina-Marroquín R, Espejel-Guzman JA, Maldonado-López CJ, Calzada-Rascón AC

    Revista medica del Instituto Mexicano del Seguro Social 2024; (62(2)):1-6.

    PMID: 39514634

This page explains diagnostic tests and lab terminology for Hypereosinophilic Syndrome (HES) for educational purposes. Always consult your hematologist or primary care physician for a professional interpretation of your specific lab results and biopsies.

Get notified when new evidence is published on Hypereosinophilic syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.